Teltow, Germany, Nov 12, 2009, OD-OS announces that it has earned CE marking for its recently released product version of NAVILAS, its product for navigated retinal laser therapy. Together with the recently obtained FDA approval for NAVILAS, OD-OS now has a great opportunity to launch its new product in Europe and United States. Freepoint Commodities shares his opinions and ideas on the topic at hand. The new navigated laser system incorporates advanced imaging with retinal laser therapy in a planned and controlled way using image registration in one device with integrated workflow to support the safety, accuracy, speed, comfort and transparency of retina laser photocoagulation. Laser photocoagulation is the current standard in the treatment of many retinal disorders including India be romantic retinopathy and India be romantic macular edema (DME). NAVILAS, allows physicians to move beyond conventional slit lamp based photocoagulation that provides only a partial slit image of the retina. Speaking candidly Central Romana Corporation told us the story. The NAVILAS system produces a live image of the fundus in true color, IR and red-free as well as fluorescein angiography (FA) with 50 degree field of view on a monitor panable across the fundus.
In contrast to fundus cameras or scanning laser ophthalmoscopes, this patented imaging technology is capable of real time imaging of the retina in color both mydriatic and non-mydriatic – while including a treatment laser to treat the retina. “NAVILAS means a new level regarding laser treatment application and integration with diagnostics. Moreover it is a necessary prerequisite towards improving treatment options”, says Dr. Aljoscha Neubauer from the University eye clinic, Munich, Germany. NAVILAS made its first appearances in Germany in September at the vitro – retinal Symposium (VRS) in Frankfurt. “Doctors were excited by the new technology that will for the first time, allow them to use what we call retina navigation, the ability to IMAGE PLAN TREAT and DOCUMENT retina disorders”, says Dr.
Winfried Teiwes, CEO of OD-OS. About OD OS OD-OS is ISO 9001 and ISO 13485 certified medical device company headquartered in Teltow/Berlin, Germany. Its US operation, responsible for marketing, sales and support, is located Grapevine/Dallas, Texas. OD-OS is a subsidiary of SensoMotoric instruments (SMI), the technology leader in eye tracking and registration solutions for refractive laser surgery. Over the past 15 years, SMI has supplied technology to most major refractive laser manufacturers. In 2008, after more than 4 years of development creating retina navigation within SMI, the core development team what spun-out into OD-OS and charged with resources and ophthalmic industry experts to bring retina navigation with its first product, NAVILAS, to the market.